BioAge Labs (BIOA) Change in Account Payables (2023 - 2026)
BioAge Labs (BIOA) reported Change in Account Payables of $326000.0 for Q1 2026, down 84.07% on a YoY basis from $2.0 million in Q1 2025, and up 114.13% sequentially from -$2.3 million in Q4 2025.
BioAge Labs (BIOA) Change in Account Payables (2023 - 2026) Analysis & Trends
BioAge Labs (BIOA) has 4 years of Change in Account Payables data on file, last reported at $326000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 84.07% year-over-year to $326000.0; the trailing twelve-month figure through Mar 2026 stood at -$933000.0 (down 155.14% YoY), and the FY2025 full-year result was $788000.0, up 13033.33% from the prior year.
- Change in Account Payables rose to $326000.0 in Q1 2026, from -$2.3 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.6 million in Q3 2025 to a low of -$2.6 million in Q2 2025.
- A 4-year average of $243200.0 and a median of $343500.0 in 2024 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 467.04% in 2025, while the deepest fall reached 1730.95% in 2025.
- Tracing BIOA's Change in Account Payables over 4 years: stood at $1.3 million in 2023, then sank by 109.6% to -$126000.0 in 2024, then plunged by 1730.95% to -$2.3 million in 2025, then jumped by 114.13% to $326000.0 in 2026.
- Business Quant data shows BIOA's Change in Account Payables at $326000.0 in Q1 2026, -$2.3 million in Q4 2025, and $3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | BioAge Labs | 930.32 Mn | 930.32 Mn | -10.37 Mn | 326,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 326,000.00 |
| Mar 31, 2026 | 326,000.00 |
| Dec 31, 2025 | -2.31 Mn |
| Dec 31, 2025 | -2.31 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | -2.60 Mn |
| Jun 30, 2025 | -2.60 Mn |
| Mar 31, 2025 | 2.05 Mn |
| Mar 31, 2025 | 2.05 Mn |
| Dec 31, 2024 | -126,000.00 |
| Dec 31, 2024 | -126,000.00 |
| Sep 30, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | -1.57 Mn |
| Jun 30, 2024 | -1.57 Mn |
| Mar 31, 2024 | 361,000.00 |
| Mar 31, 2024 | 361,000.00 |
| Dec 31, 2023 | 1.31 Mn |
| Dec 31, 2023 | 1.31 Mn |